Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for subscription

31 Oct 2019 17:02

RNS Number : 8791R
Amati AIM VCT PLC
31 October 2019
 

Amati AIM VCT plc

31 October 2019

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription

The Directors of Amati AIM VCT plc are pleased to announce that the Company has today published a prospectus (the "Prospectus") in connection with proposals to raise up to £25,000,000 (with an over-allotment facility to raise up to a further £20,000,000), by way of an offer for subscription (the "Offer") of new ordinary shares (the "New Shares") and the issue of up to a further £5,000,000 of New Shares under the Dividend Re-Investment Scheme.

The Offer will open on 31 October 2019 and will close at 12 noon on 2 April 2020 in relation to the tax year 2019/2020 and at 12 noon on 16 October 2020 in relation to the tax year 2020/2021 (unless the Offer is fully subscribed before this date and/or the Board closes the Offer earlier, which it may do in its sole discretion). Applications under the Offer will be processed from 31 October 2019. Multiple applications under the Offer from the same investor in the same tax year will not be accepted. The Directors have set the maximum amount that can be raised under the Offer prior to 31 January 2020 at £15,000,000. The amount to be raised after 31 January 2020 will be £25,000,000 less the amount already raised under the Offer (subject to any exercise of the over-allotment facility). If sufficient qualifying investments have been made from the initial proceeds of the Offer, and the Directors believe that there is a pipeline of investments to utilise the funds raised, the Board may use the over-allotment facility to raise up to a further £20 million under the Offer.

The first allotment of New Shares under the Offer is expected to take place on or around 25 November 2019 and thereafter allotments will be made on a monthly basis (or at such other times as the Board, in its sole discretion, may decide).

The number of New Shares to be issued under each allotment will be determined by the relevant offer price calculated on the following basis.

For existing shareholders and those investing through an authorised financial intermediary, the offer price is calculated by dividing the last published NAV per share at the time of allotment by 0.99 to allow for issue costs of 1% (calculated in pence and rounded up to the nearest two decimal places).For all other investors (i.e. investors other than existing shareholders and those investing through an authorised financial intermediary) the offer price is calculated by dividing the last published NAV per share at the time of allotment by 0.97 to allow for issue costs of 3% (calculated in pence and rounded up to the nearest two decimal places).

The Prospectus is available at www.amatiglobal.com and www.morningstar.co.uk/uk/nsm and, until 30 October 2020, copies are available for collection, free of charge, from the offices of Amati Global Investors and the offices of Dickson Minto W.S. on any Business Day. Copies can also be requested by contacting Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Subscriptions can be made online at www.amatioffer.com or by completing the subscription form contained in the Prospectus.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPMBBFTMBAJBFL
Date   Source Headline
30th Nov 20209:52 amRNSNet Asset Value(s)
23rd Nov 20209:08 amRNSNet Asset Value(s)
19th Nov 20204:35 pmRNSTransaction in Own Shares
16th Nov 20202:03 pmRNSNet Asset Value(s)
9th Nov 20209:06 amRNSNet Asset Value(s)
2nd Nov 20204:47 pmRNSHolding(s) in Company
2nd Nov 20204:26 pmRNSNet Asset Value(s)
2nd Nov 20209:07 amRNSTotal Voting Rights
28th Oct 20203:07 pmRNSTransaction in Own Shares
27th Oct 20203:38 pmRNSIssue of Equity
23rd Oct 20204:18 pmRNSNet Asset Value(s)
20th Oct 20204:30 pmRNSIssue of Equity
16th Oct 20204:13 pmRNSNet Asset Value(s)
13th Oct 20202:11 pmRNSTransaction in Own Shares
13th Oct 202010:27 amRNSDirector/PDMR Shareholding
13th Oct 202010:02 amRNSIssue of Equity
12th Oct 20209:06 amRNSNet Asset Value(s)
5th Oct 20203:33 pmRNSDividend Declaration
5th Oct 20203:10 pmRNSHalf-year Report
2nd Oct 20203:52 pmRNSDirector/PDMR Shareholding
2nd Oct 20203:47 pmRNSIssue of Equity
1st Oct 20204:36 pmRNSNet Asset Value(s)
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20209:34 amRNSTotal Voting Rights
25th Sep 20205:00 pmRNSNet Asset Value(s)
23rd Sep 20209:15 amRNSTransaction in Own Shares
21st Sep 20203:31 pmRNSIssue of Equity
21st Sep 20209:07 amRNSTransaction in Own Shares
21st Sep 20209:05 amRNSNet Asset Value(s)
15th Sep 20209:54 amRNSIssue of Equity
11th Sep 20204:28 pmRNSNet Asset Value(s)
8th Sep 20204:18 pmRNSTransaction in Own Shares
7th Sep 20203:01 pmRNSNet Asset Value(s)
2nd Sep 20204:56 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:55 pmRNSIssue of Equity
2nd Sep 20209:36 amRNSNet Asset Value(s)
1st Sep 202012:27 pmRNSTotal Voting Rights
25th Aug 20201:58 pmRNSUpdate on offer for subscription
21st Aug 20204:50 pmRNSNet Asset Value(s)
18th Aug 20202:50 pmRNSTransaction in Own Shares
17th Aug 202011:12 amRNSNet Asset Value(s)
14th Aug 20203:08 pmRNSTransaction in Own Shares
14th Aug 20202:36 pmRNSUpdate on offer for subscription
10th Aug 202011:49 amRNSNet Asset Value(s)
5th Aug 20203:21 pmRNSTransaction in Own Shares
4th Aug 20209:53 amRNSTotal Voting Rights
4th Aug 20208:41 amRNSNet Asset Value(s)
30th Jul 20203:15 pmRNSTransaction in Own Shares
27th Jul 20209:53 amRNSDirector/PDMR Shareholding
27th Jul 20209:43 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.